| 000 | 01900 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516081856.0 | ||
| 264 | 0 | _c20120802 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1744-6880 | ||
| 024 | 7 |
_a10.1097/FPC.0b013e3283516ff8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLynch, Amy I | |
| 245 | 0 | 0 |
_aGene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cMay 2012 |
||
| 300 |
_a355-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmlodipine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aChlorthalidone _xadministration & dosage |
| 650 | 0 | 4 |
_aCoronary Disease _xchemically induced |
| 650 | 0 | 4 |
_aDoxazosin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aLisinopril _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xchemically induced |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aEckfeldt, John H | |
| 700 | 1 | _aDavis, Barry R | |
| 700 | 1 | _aFord, Charles E | |
| 700 | 1 | _aBoerwinkle, Eric | |
| 700 | 1 | _aLeiendecker-Foster, Catherine | |
| 700 | 1 | _aArnett, Donna K | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 22 _gno. 5 _gp. 355-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0b013e3283516ff8 _zAvailable from publisher's website |
| 999 |
_c21595205 _d21595205 |
||